OKYO Pharma【OKYO】株式ニュース

名称	銘柄コード	市場	種別
OKYO Pharma Ltd	OKYO	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.0658	-4.42%	1.4242	06:00:01

始値	安値	高値	終値	前日終値
1.41	1.41	1.47	1.4242	1.49

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/4/30	20:00	GLOBE	OKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
2024/4/09	08:00	GLOBE	OKYO Pharma to Reschedule Key Opinion Leader Event in Dry..
2024/4/02	20:00	GLOBE	OKYO Pharma Announces Upcoming Presentation of OK-101 Phase..
2024/3/22	20:00	GLOBE	OKYO Pharma Announces OK-101 Successfully Achieved..
2024/3/21	20:00	GLOBE	OKYO Pharma to Host Key Opinion Leader Event to Discuss New..
2024/3/20	20:00	GLOBE	OKYO Pharma to Release New and Comprehensive Data from Phase..
2024/2/09	21:36	IHNW	OKYO Pharma Receives FDA Approval of IND for OK-101 in..
2024/2/09	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/09	21:00	GLOBE	OKYO Pharma Receives FDA Approval of IND for OK-101 in..
2024/1/31	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/31	21:00	GLOBE	OKYO Pharma Announces Distinguished Ophthalmologists with..
2024/1/08	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/08	21:00	GLOBE	OKYO Pharma Announces OK-101 Successfully Achieved..
2024/1/05	23:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/05	23:30	GLOBE	OKYO Pharma to Present at the Biotech Showcase Conference in..
2023/12/21	21:35	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/21	07:30	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/19	06:56	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/04	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/04	21:00	GLOBE	OKYO Pharma Announces Last Patient Enrolled in OK-101 Phase..
2023/11/29	21:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/02	05:55	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/01	05:59	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/31	20:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/31	20:00	GLOBE	OKYO Pharma Announces $5.84 Million Cash Raise and Payables..
2023/10/10	20:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/10	00:34	IHNW	OKYO Pharma Announces Filing of an Investigational New Drug..
2023/10/09	20:00	GLOBE	OKYO Pharma Announces Filing of an Investigational New Drug..
2023/10/05	20:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/05	20:00	GLOBE	OKYO Pharma Announces Positive Safety Data Profile for the..
2023/9/16	05:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/15	20:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/15	20:00	GLOBE	OKYO Pharma Announces Closing of $4.0 Million Registered..
2023/9/15	19:05	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/9/14	23:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/14	23:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/14	22:15	GLOBE	OKYO Pharma Announces Pricing of $4.0 Million Registered..
2023/9/14	21:45	GLOBE	OKYO Pharma Limited Announces Withdrawal of Public Offering
2023/9/14	05:13	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/9/14	05:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/14	05:05	GLOBE	OKYO Pharma Announces Public Offering of Ordinary Shares
2023/9/08	20:04	IHNW	OKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
2023/9/08	20:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/08	20:00	GLOBE	OKYO Pharma Completes Enrollment in Phase 2 Clinical Trial..
2023/8/30	20:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/30	20:00	GLOBE	OKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2..
2023/8/29	20:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/29	20:00	GLOBE	OKYO Pharma Limited Regains Compliance with Nasdaq Listing..
2023/8/26	00:33	EDGAR2	Form 20-F/A - Annual and transition report of foreign..
2023/8/15	22:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..

この銘柄に関するニュースをもっと見る »

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

OKYO OKYO Pharma Ltd

最新ニュース

チャート - 1日

チャート - 1年

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

OKYO Pharma Ltd (OKYO) ニュース

OKYO OKYO Pharma Ltd

最新ニュース

チャート - 1日

チャート - 1年

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手